课题基金 / 基金详情

基于微流控芯片技术的复方脂质体-TAT/TD生物促透给药系统的构建及作用机制研究——以藏药白脉软膏为例

批准号:
82104545
项目类别:
青年科学基金项目(C类)
资助金额:
30.0 万元
负责人:
武慧超
依托单位:
学科分类:
中药学研究新技术与新方法
结题年份:
2024
批准年份:
2021
项目状态:
已结题
项目参与者:
武慧超

项目摘要

结项摘要

相似基金

相关文献

中文摘要
构建体现整体功效的新型给药系统是突破制约中药制剂现代化发展重要瓶颈问题的途径之一。申请人前期研究白脉软膏发现其通过多成分、多途径、多靶点治疗骨关节炎,但原粉入药制成乳膏的制剂方式严重影响其疗效、质量稳定性、安全性及深层渗透性,是研究本项目关键科学问题的理想模型药物。因此,本项目拟将白脉软膏处方中饮片水提精制和提取挥发油,提取物采用微流控技术制备脂质体,借助穿透肽TAT修饰、促渗肽TD协同技术,将脂质体输送至皮肤深层,当脂质体与皮肤融合后高效促进药物渗透入组织深部,形成更适宜于复杂体系的TAT/TD生物联合促透-复方脂质体给药系统;利用药动学和药效学等方法探索其有效提高药物经皮渗透性和生物利用度的作用机制,围绕TNF、NF-κB和HIF-1信号通路阐释新型给药系统调控炎症、软骨和血管新生治疗骨关节炎的作用机制,为研究现代中药外用复方制剂提供科学思路,丰富传统医学的科学内涵。
英文摘要
It is one of the ways to break through the important bottleneck of the modernization of Traditional Chinese Medicine preparation to construct a new drug delivery system which embodies the general efficacy. The applicant's previous study on Baimai Ointment found that it treated osteoarthritis through multi-components, multi-targets and multi-pathways. However, the preparation method of making ointment from raw powder seriously affects its full function, the quality stability, safety and deep permeability. It is an ideal model drug to study the key scientific issues of this project...In this study, liposomes are prepared from the water extraction and volatile oil of Baimai ointment by microfluidics. The liposomes are modified by penetrating peptide TAT and combined with pro-osmotic peptide TD to transport the liposomes to the deep layer of skin. When the liposomes fuse into the skin, transdermal peptide TD will further penetrate them into the issues in coordination with other drugs. Thus, to form a TAT/TD liposome transdermal delivery system that is more suitable for the complex system. Then, pharmacokinetic and Pharmacodynamics methods were used to study the mechanism of its effective improvement of drug transdermal permeability and bioavailability. Focusing on the TNF signaling pathway, NF-κB signaling pathway and HIF-1 signaling pathway, the mechanism of the novel administration system regulating inflammation, cartilage and angiogenesis in the treatment of osteoarthritis was elucidated. ..To provide scientific thought for the study of TCM compound topical formulations and enrich the scientific connotation of traditional medicine.
构建体现整体功效的新型给药系统是突破制约中药制剂现代化发展重要瓶颈问题的途径之一。申请人前期研究白脉软膏发现其通过多成分、多途径、多靶点治疗骨关节炎,但原粉入药制成乳膏的制剂方式严重影响其疗效、质量稳定性、安全性及深层渗透性,是研究本项目关键科学问题的理想模型药物。因此,本项目将白脉软膏处方的复方挥发油以及脂溶性组分姜黄素、水溶性组分甘草苷和甘草酸为入药成分,采用微流控技术制备脂质体,相较于传统制备方法,微流体技术可在室温下制备,显著降低了挥发油的损耗,通过优化确定了最佳处方和制备工艺参数。对在此条件下制备的BM-Lip进行表征(n = 3),平均粒径为173.2 nm,总载药量可达12.94%,挥发油、姜黄素包封率分别为87.12%和93.43%,水溶性组分甘草酸、甘草苷包封率分别为19.41%和30.60%,该制剂在4℃下21天储藏稳定性良好。所得BM-Lip分散均匀,具有较高的稳定性。分别考察穿透肽TAT修饰、促渗肽TD协同技术,将脂质体输送至皮肤深层,当脂质体与皮肤融合后高效促进药物渗透入组织深部。在生物肽TD的辅助下,BM-Lip+TD凝胶组综合促透效果最佳,挥发油24 h单位面积累计渗透量为154.41 μg/cm2,甘草苷、甘草酸及姜黄素的24 h取样浓度分别为1.88、2.08和2.72 μg/mL。形成更适宜于复杂体系的生物促透-复方脂质体给药系统;同时考察有效提高药物经皮渗透性和生物利用度的机制,围绕TNF、NF-κB和HIF-1信号通路阐释新型给药系统调控炎症、软骨和血管新生治疗骨关节炎的作用机制。本研究运用微流控技术制备了一种“挥发油+不同极性成分”的生物深层协同促透的脂质体凝胶新型给药系统,有效增加了主要成分的深层渗透性,这一研究为微流控制备技术在中药新型外用制剂的开发提供了有价值的参考,丰富了传统医学的科学内涵。
国内基金
海外基金